Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Prepaid Assets (2016 - 2025)

Viridian Therapeutics, Inc.\DE has reported Prepaid Assets over the past 12 years, most recently at $19.6 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $19.6 million for Q4 2025, down 6.21% from a year ago — trailing twelve months through Dec 2025 was $19.6 million (down 6.21% YoY), and the annual figure for FY2025 was $19.6 million, down 6.21%.
  • Prepaid Assets for Q4 2025 was $19.6 million at Viridian Therapeutics, Inc.\DE, up from $11.0 million in the prior quarter.
  • Over the last five years, Prepaid Assets for VRDN hit a ceiling of $20.9 million in Q4 2024 and a floor of $2.7 million in Q4 2021.
  • Median Prepaid Assets over the past 5 years was $9.7 million (2023), compared with a mean of $10.0 million.
  • Biggest five-year swings in Prepaid Assets: soared 180.83% in 2023 and later fell 21.92% in 2025.
  • Viridian Therapeutics, Inc.\DE's Prepaid Assets stood at $2.7 million in 2021, then soared by 137.39% to $6.5 million in 2022, then surged by 38.11% to $9.0 million in 2023, then skyrocketed by 131.81% to $20.9 million in 2024, then dropped by 6.21% to $19.6 million in 2025.
  • The last three reported values for Prepaid Assets were $19.6 million (Q4 2025), $11.0 million (Q3 2025), and $15.4 million (Q2 2025) per Business Quant data.